The impact of social vulnerability index on survival following autologous stem cell transplant for multiple myeloma - Top-Institutions - MDSpire

The impact of social vulnerability index on survival following autologous stem cell transplant for multiple myeloma

  • By

  • Kiarash Salafian

  • Christine Mazimba

  • Leonid Volodin

  • Indumathy Varadarajan

  • Asal Pilehvari

  • Wen You

  • Ziyad O. Knio

  • Karen Ballen

  • January 18, 2024

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation
    • Health Disparities Research

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation
    • Epidemiology

  • #3

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Health Outcomes Research

  • #4

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Hematology
    • Oncology
    • Transplantation
    • Health Disparities

  • #5

    University of California San Francisco (UCSF) Medical Center
    University of California San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation
    • Population Health

Original Source(s)

The impact of social vulnerability index on survival following autologous stem cell transplant for multiple myeloma

  • by Kiarash Salafian, Christine Mazimba, Leonid Volodin, Indumathy Varadarajan, Asal Pilehvari, Wen You, Ziyad O. Knio, Karen Ballen

  • January 18, 2024

Related Content

Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies

A propensity score matching study on clinical characteristics and risk factors of herpes zoster in malignant tumor

Association of ciltacabtagene autoleucel with immune effector cell-associated enterocolitis: insights from a large national database